These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20479004)

  • 1. The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer.
    Namgoong GM; Khanal P; Cho HG; Lim SC; Oh YK; Kang BS; Shim JH; Yoo JC; Choi HS
    J Biol Chem; 2010 Jul; 285(31):23829-41. PubMed ID: 20479004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
    Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl isomerase PIN1 negatively regulates SGK1 stability to mediate tamoxifen resistance in breast cancer cells.
    Jo A; Yun HJ; Kim JY; Lim SC; Choi HJ; Kang BS; Choi BY; Choi HS
    Anticancer Res; 2015 Feb; 35(2):785-94. PubMed ID: 25667458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
    Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
    Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.
    Rajbhandari P; Finn G; Solodin NM; Singarapu KK; Sahu SC; Markley JL; Kadunc KJ; Ellison-Zelski SJ; Kariagina A; Haslam SZ; Lu KP; Alarid ET
    Mol Cell Biol; 2012 Jan; 32(2):445-57. PubMed ID: 22064478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
    Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
    Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression.
    Kim MR; Choi HS; Yang JW; Park BC; Kim JA; Kang KW
    Mol Cancer Ther; 2009 Aug; 8(8):2163-71. PubMed ID: 19671742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolyl-isomerase Pin1 impairs trastuzumab sensitivity by up-regulating fatty acid synthase expression.
    Yun HJ; Kim JY; Kim G; Choi HS
    Anticancer Res; 2014 Mar; 34(3):1409-16. PubMed ID: 24596388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition.
    Kim JA; Kim MR; Kim O; Phuong NT; Yun J; Oh WK; Bae K; Kang KW
    Food Chem Toxicol; 2012 Oct; 50(10):3625-34. PubMed ID: 22842120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.
    Kim MR; Choi HK; Cho KB; Kim HS; Kang KW
    Cancer Sci; 2009 Oct; 100(10):1834-41. PubMed ID: 19681904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation.
    Lee NY; Choi HK; Shim JH; Kang KW; Dong Z; Choi HS
    Carcinogenesis; 2009 Apr; 30(4):671-81. PubMed ID: 19168580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies.
    Wu W; Xue X; Chen Y; Zheng N; Wang J
    Pharmacol Res; 2022 Oct; 184():106456. PubMed ID: 36116709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.
    Rajbhandari P; Ozers MS; Solodin NM; Warren CL; Alarid ET
    J Biol Chem; 2015 May; 290(22):13749-62. PubMed ID: 25866209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells.
    Oh SJ; Kim O; Lee JS; Kim JA; Kim MR; Choi HS; Shim JH; Kang KW; Kim YC
    Food Chem Toxicol; 2010 Nov; 48(11):3227-34. PubMed ID: 20804812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer.
    Lucchetti C; Caligiuri I; Toffoli G; Giordano A; Rizzolio F
    PLoS One; 2013; 8(2):e55355. PubMed ID: 23390529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
    Kim G; Khanal P; Kim JY; Yun HJ; Lim SC; Shim JH; Choi HS
    Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
    Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW
    J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
    Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
    Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
    Mathur R; Chandna S; N Kapoor P; S Dwarakanath B
    Curr Cancer Drug Targets; 2011 Mar; 11(3):380-92. PubMed ID: 21247380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPA-induced cell transformation provokes a complex formation between Pin1 and 90 kDa ribosomal protein S6 kinase 2.
    Cho YS; Park SY; Kim DJ; Lee SH; Woo KM; Lee KA; Lee YJ; Cho YY; Shim JH
    Mol Cell Biochem; 2012 Aug; 367(1-2):85-92. PubMed ID: 22562304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.